Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility

Jason R. Kovac, J. Scovell, Ranjith Ramasamy, S. Rajanahally, R. M. Coward, R. P. Smith, L. I. Lipshultz

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We examined whether men with anabolic-steroid-induced hypogonadism (ASIH) seeking testosterone supplementation therapy (TST) regretted their decision to use anabolic-androgenic steroids (AAS) and what their reasons were for this regret. An anonymous, prospective survey was distributed to 382 men seeking follow-up treatment for hypogonadism. Prior AAS use was confirmed by self-report, and men were categorised based upon whether they regretted (R) or did not regret (NR) their use of AAS. The average patient age was 40 ± 0.9 years (n = 79) and 15.2% expressed regret over AAS use. No demographic differences were identified between those who regretted AAS use (n = 12) and those who did not (n = 67). Regret was not related to ASIH diagnosis or to AAS-related side effects like increased aggression, mood disorders, erectile dysfunction, acne, fluid retention or dyslipidemia. Those who regretted AAS use were significantly more likely to have not comprehended the negative impact on future fertility (P <0.030). Actual fertility issues were comparable in men who regretted AAS use (16.7%) and those who did not (13%). A total of 15.2% of men regretted using AAS. A lack of awareness regarding the negative long-term effects on fertility was the primary factor related to regret of AAS use in men with ASIH.

Original languageEnglish (US)
Pages (from-to)872-878
Number of pages7
JournalAndrologia
Volume47
Issue number8
DOIs
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Testosterone Congeners
Fertility
Emotions
Hypogonadism
Acne Vulgaris
Erectile Dysfunction
Dyslipidemias
Aggression
Mood Disorders

Keywords

  • Anabolic steroids
  • Hypogonadism
  • Infertility
  • Regret
  • Testosterone

ASJC Scopus subject areas

  • Urology
  • Endocrinology

Cite this

Kovac, J. R., Scovell, J., Ramasamy, R., Rajanahally, S., Coward, R. M., Smith, R. P., & Lipshultz, L. I. (2015). Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility. Andrologia, 47(8), 872-878. https://doi.org/10.1111/and.12340

Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility. / Kovac, Jason R.; Scovell, J.; Ramasamy, Ranjith; Rajanahally, S.; Coward, R. M.; Smith, R. P.; Lipshultz, L. I.

In: Andrologia, Vol. 47, No. 8, 01.10.2015, p. 872-878.

Research output: Contribution to journalArticle

Kovac, JR, Scovell, J, Ramasamy, R, Rajanahally, S, Coward, RM, Smith, RP & Lipshultz, LI 2015, 'Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility', Andrologia, vol. 47, no. 8, pp. 872-878. https://doi.org/10.1111/and.12340
Kovac, Jason R. ; Scovell, J. ; Ramasamy, Ranjith ; Rajanahally, S. ; Coward, R. M. ; Smith, R. P. ; Lipshultz, L. I. / Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility. In: Andrologia. 2015 ; Vol. 47, No. 8. pp. 872-878.
@article{897e625df06442539bdb1a31a36da375,
title = "Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility",
abstract = "We examined whether men with anabolic-steroid-induced hypogonadism (ASIH) seeking testosterone supplementation therapy (TST) regretted their decision to use anabolic-androgenic steroids (AAS) and what their reasons were for this regret. An anonymous, prospective survey was distributed to 382 men seeking follow-up treatment for hypogonadism. Prior AAS use was confirmed by self-report, and men were categorised based upon whether they regretted (R) or did not regret (NR) their use of AAS. The average patient age was 40 ± 0.9 years (n = 79) and 15.2{\%} expressed regret over AAS use. No demographic differences were identified between those who regretted AAS use (n = 12) and those who did not (n = 67). Regret was not related to ASIH diagnosis or to AAS-related side effects like increased aggression, mood disorders, erectile dysfunction, acne, fluid retention or dyslipidemia. Those who regretted AAS use were significantly more likely to have not comprehended the negative impact on future fertility (P <0.030). Actual fertility issues were comparable in men who regretted AAS use (16.7{\%}) and those who did not (13{\%}). A total of 15.2{\%} of men regretted using AAS. A lack of awareness regarding the negative long-term effects on fertility was the primary factor related to regret of AAS use in men with ASIH.",
keywords = "Anabolic steroids, Hypogonadism, Infertility, Regret, Testosterone",
author = "Kovac, {Jason R.} and J. Scovell and Ranjith Ramasamy and S. Rajanahally and Coward, {R. M.} and Smith, {R. P.} and Lipshultz, {L. I.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/and.12340",
language = "English (US)",
volume = "47",
pages = "872--878",
journal = "Andrologia",
issn = "0303-4569",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility

AU - Kovac, Jason R.

AU - Scovell, J.

AU - Ramasamy, Ranjith

AU - Rajanahally, S.

AU - Coward, R. M.

AU - Smith, R. P.

AU - Lipshultz, L. I.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - We examined whether men with anabolic-steroid-induced hypogonadism (ASIH) seeking testosterone supplementation therapy (TST) regretted their decision to use anabolic-androgenic steroids (AAS) and what their reasons were for this regret. An anonymous, prospective survey was distributed to 382 men seeking follow-up treatment for hypogonadism. Prior AAS use was confirmed by self-report, and men were categorised based upon whether they regretted (R) or did not regret (NR) their use of AAS. The average patient age was 40 ± 0.9 years (n = 79) and 15.2% expressed regret over AAS use. No demographic differences were identified between those who regretted AAS use (n = 12) and those who did not (n = 67). Regret was not related to ASIH diagnosis or to AAS-related side effects like increased aggression, mood disorders, erectile dysfunction, acne, fluid retention or dyslipidemia. Those who regretted AAS use were significantly more likely to have not comprehended the negative impact on future fertility (P <0.030). Actual fertility issues were comparable in men who regretted AAS use (16.7%) and those who did not (13%). A total of 15.2% of men regretted using AAS. A lack of awareness regarding the negative long-term effects on fertility was the primary factor related to regret of AAS use in men with ASIH.

AB - We examined whether men with anabolic-steroid-induced hypogonadism (ASIH) seeking testosterone supplementation therapy (TST) regretted their decision to use anabolic-androgenic steroids (AAS) and what their reasons were for this regret. An anonymous, prospective survey was distributed to 382 men seeking follow-up treatment for hypogonadism. Prior AAS use was confirmed by self-report, and men were categorised based upon whether they regretted (R) or did not regret (NR) their use of AAS. The average patient age was 40 ± 0.9 years (n = 79) and 15.2% expressed regret over AAS use. No demographic differences were identified between those who regretted AAS use (n = 12) and those who did not (n = 67). Regret was not related to ASIH diagnosis or to AAS-related side effects like increased aggression, mood disorders, erectile dysfunction, acne, fluid retention or dyslipidemia. Those who regretted AAS use were significantly more likely to have not comprehended the negative impact on future fertility (P <0.030). Actual fertility issues were comparable in men who regretted AAS use (16.7%) and those who did not (13%). A total of 15.2% of men regretted using AAS. A lack of awareness regarding the negative long-term effects on fertility was the primary factor related to regret of AAS use in men with ASIH.

KW - Anabolic steroids

KW - Hypogonadism

KW - Infertility

KW - Regret

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=84940897882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940897882&partnerID=8YFLogxK

U2 - 10.1111/and.12340

DO - 10.1111/and.12340

M3 - Article

C2 - 25220690

AN - SCOPUS:84940897882

VL - 47

SP - 872

EP - 878

JO - Andrologia

JF - Andrologia

SN - 0303-4569

IS - 8

ER -